Literature DB >> 10718348

Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine.

T Ikeda1, K Iwata, H Murakami.   

Abstract

To investigate the effect of metformin on intestinal glucose absorption, a perfusion study of the intestine was performed in the rat. Male Wistar albino rats (8 weeks old) were used in the present study. The glucose absorption by the perfused intestine (788.1+/-81.9 micromol/30 min) was not changed significantly by the direct addition of metformin (90 microg/mL) to the perfusing medium (737.0+/-118.2 micromol/30 min) or by intraduodenal metformin (250 mg/kg in saline solution) infusion (772.8+/-106.3 micromol/30 min). In rats orally administered metformin (250 mg/kg) for 5 days, glucose absorption by the perfused intestine (375.0+/-164.3 micromol/30 min) was significantly (P<0.001) lower than that in control rats (811.0+/-83.1 micromol/30 min). These results indicate that metformin had a significant effect on the digestive tract, and that metformin treatment exerted an inhibitory effect on intestinal glucose absorption in the rat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718348     DOI: 10.1016/s0006-2952(99)00396-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice.

Authors:  Joanne S Allard; Evelyn J Perez; Koji Fukui; Priscilla Carpenter; Donald K Ingram; Rafael de Cabo
Journal:  Behav Brain Res       Date:  2015-12-14       Impact factor: 3.332

Review 2.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

3.  Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.

Authors:  Hao Cai; Ruth S Everett; Dhiren R Thakker
Journal:  Br J Pharmacol       Date:  2019-06-26       Impact factor: 8.739

4.  Targeting Oxygen-Sensing Prolyl Hydroxylase for Metformin-Associated Lactic Acidosis Treatment.

Authors:  Tomoko Oyaizu-Toramaru; Tomohiro Suhara; Noriyo Hayakawa; Takashi Nakamura; Akiko Kubo; Shizuka Minamishima; Kyoji Yamaguchi; Takako Hishiki; Hiroshi Morisaki; Makoto Suematsu; Yoji Andrew Minamishima
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

Review 5.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.

Authors:  A Natali; E Ferrannini
Journal:  Diabetologia       Date:  2006-02-14       Impact factor: 10.122

7.  Management of type 2 diabetes mellitus associated with pituitary gigantism.

Authors:  Omar Ali; Swati Banerjee; Daniel F Kelly; Phillip D K Lee
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

8.  Glycemic index, glycemic load, and glycemic response to pomelo in patients with type 2 diabetes.

Authors:  Shi-Ying Shao; Wei-Jie Xu; Jing Tao; Jian-Hua Zhang; Xin-Rong Zhou; Gang Yuan; Yan Yang; Jing Zhang; Hong-Yan Zhang; Qiang Xu; Xiu-Xin Deng; Shu-Hong Hu; Mu-Xun Zhang; Zhe-Long Liu; Xue-Feng Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

9.  Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug.

Authors:  Tamer Ozülker; Filiz Ozülker; Meral Mert; Tevfik Ozpaçaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-27       Impact factor: 9.236

10.  Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.